Director acquires 28,185 MicroVision (MVIS) shares at $0.5322 under subscription

Rhea-AI Filing Summary

MicroVision director Jeffrey A. Herbst acquired 28,185 shares of common stock directly from the company at $0.5322 per share under a Subscription Agreement executed on March 15, 2026. The purchase price matched the closing share price on March 13, 2026 and is intended to qualify as an exempt transaction under Rule 16b-3. Following this acquisition, Herbst directly holds 258,912 shares of MicroVision common stock.

Insights

Insider transactions analyst

Director acquires shares directly from MicroVision in a Rule 16b-3 exempt deal, a routine, neutral-strength insider transaction.

Director Jeffrey A. Herbst acquired 28,185 MicroVision shares at $0.5322 per share via a Subscription Agreement with the company. The price equals the March 13, 2026 closing price, indicating a purchase at prevailing market levels rather than a discounted insider deal.

The transaction is intended to be exempt under Rule 16b-3, which typically covers issuer-approved grants or purchases by insiders. Herbst’s direct holdings rise to 258,912 shares after the transaction. Given the single, modest-sized acquisition and lack of related sales or derivative exercises, this appears to be a routine governance-approved equity purchase with neutral implication for investors.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Herbst Jeffrey A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	28,185	$0.5322	$15K

Holdings After Transaction: Common Stock — 258,912 shares (Direct)

Footnotes (1)

1. Pursuant to a Subscription Agreement executed on March 15, 2026 between MicroVision, Inc. ("MicroVision") and the reporting person, the reporting person acquired 28,185 shares of MicroVision's common stock directly from MicroVision at a purchase price of $0.5322 per share, the closing price of MicroVision's common stock on March 13, 2026. The purchase is intended to be an exempt transaction pursuant to Rule 16b-3.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Herbst Jeffrey A

(Last) (First) (Middle)

18390 NE 68TH STREET

(Street)

REDMOND WA 98052

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROVISION, INC. [ MVIS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	03/15/2026		A(2)		28,185	A	$0.5322	258,912	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to a Subscription Agreement executed on March 15, 2026 between MicroVision, Inc. ("MicroVision") and the reporting person, the reporting person acquired 28,185 shares of MicroVision's common stock directly from MicroVision at a purchase price of $0.5322 per share, the closing price of MicroVision's common stock on March 13, 2026.

2. The purchase is intended to be an exempt transaction pursuant to Rule 16b-3.

	/s/ Drew G. Markham, attorney-in-fact for Jeffrey A. Herbst	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did MicroVision (MVIS) director Jeffrey A. Herbst report?

Director Jeffrey A. Herbst reported acquiring 28,185 shares of MicroVision common stock. The shares were bought directly from the company through a Subscription Agreement at a set per-share price, increasing his direct ownership position in MicroVision stock to 258,912 shares after the transaction.

At what price did the MicroVision (MVIS) director acquire the 28,185 shares?

Jeffrey A. Herbst acquired the 28,185 MicroVision shares at $0.5322 per share

How many MicroVision (MVIS) shares does Jeffrey A. Herbst own after this Form 4 transaction?

After the reported acquisition, Jeffrey A. Herbst directly owns 258,912 shares of MicroVision common stock. This total reflects the addition of 28,185 shares purchased from the company under the Subscription Agreement described in the Form 4 and associated footnotes.

Was the MicroVision (MVIS) director’s share acquisition an exempt insider transaction?

Yes, the filing states the purchase is intended to be an exempt transaction under Rule 16b-3. That rule generally covers issuer-approved equity transactions with directors or officers, which are structured to avoid short-swing profit liability while still requiring public disclosure through Form 4.

Did the MicroVision (MVIS) director buy the shares on the open market?

No, the 28,185 shares were acquired directly from MicroVision under a Subscription Agreement. Although the price matched the market closing price on March 13, 2026, the transaction was between the company and the director rather than a standard open-market purchase on a stock exchange.

What does the Subscription Agreement mean in the MicroVision (MVIS) Form 4 filing?

The Subscription Agreement is the contract under which MicroVision issued 28,185 shares to director Jeffrey A. Herbst at $0.5322 per share. It formalizes the purchase directly from the company and supports the characterization of the transaction as intended to be exempt under Rule 16b-3.